Q3 2023 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to the BioCryst Pharmaceuticals' Third Quarter 2023 Earnings Conference Call. (Operator Instructions). Please note, this event is being recorded.
I would like now to turn the conference over to John Bluth at BioCryst. Please go ahead.
Thank you, Maria. Good morning, and welcome to BioCryst's Third Quarter 2023 Corporate Update and Financial Results Conference Call. Today's press release and accompanying slides are available on our website. Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Commercial Officer, Charlie Gayer and Chief Data and Insights Officer, Jinky Rosselli. Following our remarks, we'll answer your questions.
As a reminder, tomorrow at 1:00 p.m. Eastern Time, we'll be hosting an R&D Day where we plan to describe our drug discovery process and introduce additional therapies from our pipeline. So today, we'll focus on ORLADEYO, and tomorrow, we'll take a deep dive and answer your question on our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |